NCT02895919

Brief Summary

This study seeks to determine non inferiority of direct inoculation of ascitic fluid in lab as compared to current culture media standard, bedside inoculation with blood culture bottles.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2016

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 22, 2016

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 31, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 12, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2018

Completed
Last Updated

December 11, 2019

Status Verified

December 1, 2019

Enrollment Period

2 years

First QC Date

August 31, 2016

Last Update Submit

December 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Growth of bacteria on ascitic fluid culture

    Non inferiority of direct inoculation in laboratory as compared to bedside inoculation with blood culture bottles by comparing growth of bacterial growth between both groups, control and study arm.

    through study completion, an average of 1 year to complete enrollment of 460 patients

Secondary Outcomes (1)

  • Time to positive ascitic fluid culture

    through study completion, an average of 1 year

Study Arms (2)

Control group - blood culture bottles

Standard of care group for control - will inoculate all samples in blood culture bottles for ascitic fluid culture

Other: Culture

Study group - sample to lab for culture

Study group - will send a sample of ascitic fluid to lab for inoculation in addition to control sample

Other: Culture

Interventions

CultureOTHER

culture of ascitic fluid in standard culture media of blood culture bottles at bedside and fluid collected for culture in laboratory (study arm).

Control group - blood culture bottlesStudy group - sample to lab for culture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient population will include all patients undergoing diagnostic paracentesis comparing standard culture protocol (bedside inoculation of blood culture bottles with ascitic fluid) with an additional culture collected for study arm. Patients will be all comers for diagnostic paracentesis.

You may qualify if:

  • Ascites on ultrasound

You may not qualify if:

  • Consent declined

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AscitesPeritonitis

Interventions

Culture Techniques

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsIntraabdominal InfectionsInfectionsPeritoneal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

In Vitro TechniquesInvestigative Techniques

Study Officials

  • Ricardo Franco Sadud, MD

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2016

First Posted

September 12, 2016

Study Start

August 22, 2016

Primary Completion

August 19, 2018

Study Completion

August 19, 2018

Last Updated

December 11, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will share